TOKYO, Dec 11, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has received approval for “URECE®” (brand name in China: “优乐思®”, generic name: dotinurad) from the National Medical ...

Febuxostat is not recommended for the treatment of patients with secondary hyperuricemia, such as those being treated for Lesch-Nyhan syndrome or cancer or those receiving organ transplants.

American interest in secondary passports has been on the rise over the last year — and global citizenship firms have reported another surge since Donald Trump's reelection. "We are beyond busy ...

The presentation highlights XORTX recent pioneering discoveries in the field of Autosomal Dominant Polycystic Kidney Disease (“ADPKD”), and recent peer-reviewed, independent, published research ...

Rigel Pharmaceuticals (RIGL) announced initial data from its ongoing Phase 1b study evaluating R2891, an oral prodrug of R835, a potent and ...

Nonalcoholic fatty liver disease (NAFLD) is characterized by over 5% hepatic fat accumulation without secondary causes. The prevalence of NAFLD has escalated ... may possess greater potential for ...

In medicine, there are four levels of care: primary, secondary, tertiary, and quaternary. The levels of care refer to the complexity of the medical cases that healthcare providers treat and the skills ...

Amid cuts to staff, programs and student services, Canada's post-secondary system is moving into a stormy period. Students, faculty, post-secondary institutions and experts predict challenging ...

The primary endpoint of the SOS study was mortality.28 Secondary endpoints included type 2 diabetes and cardiovascular disease. Gout incidence was not a predefined endpoint. Type 2 diabetes was ...